Skip to content

A Study With Health Educational Material on Health Promotion in Cancer Survivors

A Randomized Controlled Trial on the Effect of Intervention With Health Educational Material on Knowledge, Attitude, and Behavior in Cancer Survivors

Status
UNKNOWN
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00948337
Enrollment
326
Registered
2009-07-29
Start date
2009-08-31
Completion date
2010-12-31
Last updated
2010-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Colon Cancer, Stomach Cancer, Thyroid Cancer

Brief summary

The purpose of this study is to provide educational material to promote screening for second primary cancer for the intervention group, or educational material to instruct appropriate use of dietary supplement for the control group.

Interventions

BEHAVIORALBrochure of Secondary Cancer Screening

One kind of printed educational material

Sponsors

National Cancer Center, Korea
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Age \>=18, \<80 * Cancer survivors (pathologically confirmed) * Finished primary treatment (surgery, radiotherapy, chemotherapy) * \>= 1 year from cancer diagnosis * No evidence of recurrence, metastasis, and second primary cancer * No evidence of hereditary cancer * ECOG 0,1,2 * Ability in reading Korean educational material

Exclusion criteria

* ECOG 3,4 * Disagree with the investigators study purpose

Design outcomes

Primary

MeasureTime frame
Screening behavior for second primary cancerAfter 1 yr

Secondary

MeasureTime frame
Knowledge and attitudes of Secondary cancer screening and dietary supplementIn 2 weeks

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 26, 2026